LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.67 | 17.25 | 2120 | 1653 | 1.2824 | 1.0770 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 28.67 | 17.25 | 2221 | 1653 | 1.3435 | 1.0918 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.64 | 17.25 | 1 | 1887 | 0.0005 | -0.3433 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.64 | 17.25 | 2238 | 1887 | 1.1857 | 1.0509 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.64 | 17.25 | 2401 | 1887 | 1.2721 | 1.0723 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.64 | 17.25 | 2474 | 1887 | 1.3108 | 1.0815 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.61 | 17.25 | 2 | 2136 | 0.0009 | -0.2665 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.61 | 17.25 | 2449 | 2136 | 1.1463 | 1.0397 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.61 | 17.25 | 2671 | 2136 | 1.2503 | 1.0653 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.61 | 17.25 | 2719 | 2136 | 1.2727 | 1.0706 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.57 | 17.25 | 3 | 2523 | 0.0012 | -0.2159 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.57 | 17.25 | 2632 | 2523 | 1.0431 | 1.0118 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.57 | 17.25 | 2915 | 2523 | 1.1553 | 1.0405 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.57 | 17.25 | 2970 | 2523 | 1.1771 | 1.0459 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.54 | 17.25 | 2 | 2679 | 0.0007 | -0.2562 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.54 | 17.25 | 2891 | 2679 | 1.0788 | 1.0210 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.54 | 17.25 | 3053 | 2679 | 1.1393 | 1.0361 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.54 | 17.25 | 3116 | 2679 | 1.1628 | 1.0419 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.51 | 17.25 | 8 | 2906 | 0.0028 | -0.0987 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.51 | 17.25 | 3058 | 2906 | 1.0523 | 1.0138 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.51 | 17.25 | 3329 | 2906 | 1.1455 | 1.0371 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.51 | 17.25 | 3362 | 2906 | 1.1569 | 1.0398 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.48 | 17.25 | 6 | 3125 | 0.0019 | -0.1313 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.48 | 17.25 | 3341 | 3125 | 1.0689 | 1.0178 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 40.48 | 17.25 | 3531 | 3125 | 1.1296 | 1.0328 | MN20160310_N02 | L04 |